7150-01-8

Usage

Uses

Used in Pharmaceutical and Agrochemical Industries:
2-ACETOXY-3-METHOXYBENZALDEHYDE 97 is used as a key intermediate in the synthesis of various pharmaceuticals and agrochemicals. Its role in these industries is vital for the development of new drugs and agricultural products, contributing to advancements in healthcare and agriculture.
Used in Flavor and Fragrance Industry:
In the flavor and fragrance industry, 2-ACETOXY-3-METHOXYBENZALDEHYDE 97 is utilized as an agent to impart specific scents and flavors to products. Its use in perfumes and cosmetics enhances the sensory experience of consumers, adding value to these products.
Used in Research and Industrial Applications:
Due to its high purity, 2-ACETOXY-3-METHOXYBENZALDEHYDE 97 is also employed in research and industrial applications. Its versatility and purity make it suitable for a wide range of experiments and processes, contributing to scientific discoveries and the development of new products.

InChI:InChI=1/C10H10O4/c1-7(12)14-10-8(6-11)4-3-5-9(10)13-2/h3-6H,1-2H3

Upstream product

• 110-86-1 pyridine 
• 108-24-7 acetic anhydride 
• 148-53-8 3-methoxy-2-hydroxybenzaldehyde 
• 75-36-5 acetyl chloride 

Downstream Products

• 122273-38-5 (2-acetoxy-3-methoxy-phenyl)-bis-(4-hydroxy-2-oxo-2H-chromen-3-yl)-methane 
• 23000-32-0 8-methoxy-3-phenyl-2H-chromen-2-one 
• 20878-95-9 3t-(2-acetoxy-3-methoxy-phenyl)-2-phenyl-acrylic acid 
• 2426-86-0 2-hydroxy-3-methoxy-6-nitrobenzaldehyde 
• 20041-61-6 2-hydroxy-3-methoxy-4-nitrobenzaldehyde 
• 60582-30-1 3-methoxysalicylaldehyde dimethyl acetal 
• 115061-13-7 4-t-butyl 1-methyl (E)-2-(2-acetoxy-3-methoxyphenylmethylene)butadienoate 
• 138116-13-9 3-(Diphenyl-phosphinoyl)-8-methoxy-chromen-2-one 
• 20035-41-0 6-bromo-2-hydroxy-3-methoxybenzaldehyde 
• 159263-87-3 2-acetyloxy-3-methoxy-6-bromobenzaldehyde 
• 54208-18-3 α-phenyl-2'-acetoxy-3'-methoxycinnamic acid 
• 54208-20-7 (E)-3-(2-Acetoxy-3-methoxy-phenyl)-2-(3,4-dimethoxy-phenyl)-acrylic acid 
• 183005-89-2 2-acetoxy-3-methoxy-6-nitro-benzaldehyde 
• 54208-22-9 3-(3,4-dimethoxyphenyl)-8-methoxy-2H-chromen-2-one 

Relevant academic research and scientific papers

Overcoming AlbD Protease Resistance and Improving Potency: Synthesis and Bioactivity of Antibacterial Albicidin Analogues with Amide Bond Isosteres

Albicidin is a potent antibacterial oligoaromatic peptide that is susceptible to the protease AlbD, a resistance factor. This potentially restricts the use of albicidin as a drug. To overcome this obstacle, we synthesized and evaluated six analogues with

Boron Containing PDE4 Inhibitors

The present invention relates to boron containing compounds of Formula (I) [in-line-formulae]X—Y—Z?? Formula (I)[/in-line-formulae] that inhibit phosphodiesterase 4 (PDE4). The invention also encompasses pharmaceutical compositions containing these compounds and methods for treating diseases, conditions, or disorders ameliorated by inhibition of PDE4.

The first total synthesis of (±)-methyl salvianolate A using a convergent strategy

Herein, a convergent, practicable and first total synthesis of the natural product, (±)-methyl salvianolate A, is reported. The key features of the approach are the use of a Horner–Wadsworth–Emmons reaction and the protection of multiple hydroxyls using s

COMPOUNDS FOR TREATMENT OF CARDIAC ARRHYTHMIAS AND HEART FAILURE

This disclosure concerns compounds and a method for modulating the activity of calcium ion channels, including Ca2+-induced (or Ca2+-activated) calcium release channels and conformationally coupled calcium release channels such as ryanodine receptors. Some of the compounds have a structure according to formula I, or a stereoisomer, tautomer, hydrate, solvate, prodrug, or pharmaceutically acceptable salt thereof.

Salvianolic acid A intermediate and preparation method thereof

The invention relates to a medicine salvianolic acid A intermediate used for treating angina and acute myocardial infarction, i.e., a new synthesis method for trans-3-bromo-2-(3,4-di-substituted styryl)-6-substituted phenol. The method comprises the follo

Fibrauretine synthetic method (by machine translation)

The invention relates to O-vanillin (11) as the starting material, by the acylation reaction generating 2 - acetoxy - 3 - methoxybenzaldehyde (12), by the bromo, hydrolysis reaction to produce the 2 - hydroxy - 6 - bromo - 3 - methoxybenzaldehyde (13), produced by the methylation reaction 6 - bromo - 2, 3 - dimethoxy benzaldehyde (14), produced by the condensation reaction of 2 - (6 - bromo - 2, 3 - dimethoxyphenyl) - 1, 3 - dioxolane (15); and then to 3, 4 - dimethoxy acetic acid (21) as raw materials, generated by the reduction reaction of the 3, 4 - dimethoxy ethanol (22), the acylation reaction generated by 3, 4 - dimethoxy new valeric acid environmentally (23), the acylation reaction is generated by the 2 - ethoxy - 3, 4 - dimethoxy new valeric acid environmentally (24), intermediate (15) and (24) after coupling, cyclized two-step reaction process for preparing the target product fibrauretin. (by machine translation)

Synthesis of (+)-salvianolic acid A from sodium Danshensu

(+)-Salvianolic acid A, one of the most active components in the traditional Chinese medicine Danshen, has been synthesized over 10 steps in 6.5% overall yield. Starting from inexpensive ortho-vanillin and sodium Danshensu (synthesized via asymmetric catalysis in our group), the process consists of the following: A Wittig reaction that gives the desire product with absolute E-configuration, a demethylation reaction with AlCl3 in a satisfactory yield, and a practical deprotection of allylic groups to afford the terminal product (+)-salvianolic acid A. The current synthetic technology possesses the advantages of using inexpensive starting materials, mild reaction conditions and has the potential for use in large scale synthesis.

Synthesis of SMND-309, a derivate of salvianolic acid B

(E)-2-(6-((E)-2-carboxyvinyl)-2,3-dihydroxyphenyl)-3-(3,4-dihydroxyphenyl) acrylic acid, designated SMND-309, was synthesized starting from 2-hydroxy-3-methoxybenzaldehyde in 12 steps and with an overall yield of 44%. The synthetic key features were the c

Method for synthesizing natural product salvianolic acid A methyl ester

The invention relates to a novel method for synthesizing natural product salvianolic acid A methyl ester. A synthetic route is unique and novel in design; key strategies and steps comprise the step of using an easily-removed t-butyldimethylsilyl protectin

New synthesis method of natural product Salvianolic Acid F

The invention discloses a new synthesis method of a natural product Salvianolic Acid F. The method comprises the following steps: carrying out hydroxyl group protection on 4-methycatechol used as a raw material, carrying out a methyl radical reaction, and